At Queen’s Neuroscience Institute, our team is dedicated to providing state-of-the-art medical care for patients with a wide range of neurological and neurosurgical conditions and diseases. Our primary goal is to improve the neurological health of the people of Hawaii through expert treatment and rehabilitation for improved quality of life.
Our specialists provide comprehensive multidisciplinary, patient-centered care in both an acute hospital and outpatient setting.
Queen’s Neuroscience Institute team provides expert care across a range of neurological conditions and includes:
We are the national leader in health disparities research assessing stroke-related disparities among Native Hawaiians and other Pacific Islanders. The Queen’s Medical Center established the Neuroscience Institute in 1996 with the mission to provide state-of-the-art medical care to patients with neurological conditions and diseases. Through the integration of clinical excellence, education and research, our specialists improve the lives of our patients, every day. This Center of Excellence embodies the full spectrum of care, from our inpatient Neuroscience Intensive Care Unit and dedicated neuroscience floors, to our specialty outpatient clinics.
Our Stroke Center was opened in 1997 and was designated by The Joint Commission as a Primary Stroke Center in 2004. In 2016, Queen’s Neuroscience Institute achieved The Joint Commission’s highest level of stroke accreditation to become the state of Hawaii’s first Comprehensive Stroke Center.
The Comprehensive Epilepsy Center at The Queen’s Medical Center Neuroscience Institute is accredited by the NAEC (National Association of Epilepsy Centers) as Hawaii’s only Level 4 Comprehensive Epilepsy Center. Level 4 epilepsy centers have the professional expertise and facilities to provide the highest level medical and surgical evaluation and treatment for patients with complex epilepsy.
Our specialized neurology team is committed to keeping the Health of Hawaii Strong.
As a part of its mission to educate and improve the health care of the people of Hawaii, the Queen’s Neuroscience Institute is active in continuing to educate physicians, nurses and the community through a variety of clinical and community outreach efforts, and partnerships with local non-profit organizations.
Some of our educational programs include:
Some of our outreach efforts include:
Research is central to the NSI’s commitment to advanced treatments and education for providers and staff. We partner with national institutions and researchers to bring expanded opportunities and the highest level of care to our patients. Since its inception, the NSI has participated in studies involving new devices to treat aneurysms and to cool the body and brain. It has participated in studies involving traumatic brain injury, spinal cord injury, and seizures, including over 30 clinical stroke trials with Hawai‘i residents. The NSI also maintains a comprehensive stroke database.
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction. PI: Dr. Kazuma Nakagawa.
The Comprehensive Epilepsy Center participates in national clinical trials as well. Other national and international studies include research in traumatic brain injuries, devices, imaging, spinal cord surgery and injury, and improving rehabilitation.
For more information about clinical trials, you can contact us at NeuroscienceResearch@Queens.org.